TP53 and breast carcinoma: Using the metastatic breast cancer MDA-MB-231 cell line, our group showed that AP4 can activate cell migration and invasion by activating the mutant p53-R280K protein, and the expression of dominant-negative AP4, which lacks the DNA-binding domain, decreases cell mobility [62].